These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36840006)

  • 1. Development of Triamcinolone Acetonide Nanocrystals for Ocular Administration.
    Formica ML; Awde Alfonso HG; Paredes AJ; Melian ME; Camacho NM; Faccio R; Tártara LI; Palma SD
    Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36840006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triamcinolone acetonide-loaded lipid nanocapsules for ophthalmic applications.
    Formica ML; Ullio Gamboa GV; Tártara LI; Luna JD; Benoit JP; Palma SD
    Int J Pharm; 2020 Jan; 573():118795. PubMed ID: 31682964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Situ Gel of Triamcinolone Acetonide-Loaded Solid Lipid Nanoparticles for Improved Topical Ocular Delivery: Tear Kinetics and Ocular Disposition Studies.
    Tatke A; Dudhipala N; Janga KY; Balguri SP; Avula B; Jablonski MM; Majumdar S
    Nanomaterials (Basel); 2018 Dec; 9(1):. PubMed ID: 30591688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymeric micelles for the ocular delivery of triamcinolone acetonide: preparation and
    Safwat MA; Mansour HF; Hussein AK; Abdelwahab S; Soliman GM
    Drug Deliv; 2020 Dec; 27(1):1115-1124. PubMed ID: 32720545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and pharmacodynamics of suprachoroidal injection of triamcinolone acetonide as a controlled ocular drug release model.
    Chen M; Li X; Liu J; Han Y; Cheng L
    J Control Release; 2015 Apr; 203():109-17. PubMed ID: 25700623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Directing the nanoparticle formation by the combination with small molecular assembly and polymeric assembly for topical suppression of ocular inflammation.
    Huang J; Yu X; Zhou Y; Zhang R; Song Q; Wang Q; Li X
    Int J Pharm; 2018 Nov; 551(1-2):223-231. PubMed ID: 30213683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, optimization, in vitro and in vivo evaluation of triamcinolone acetonide nanocrystals loaded in situ gel for topical ocular delivery.
    Khan MS; Ravi PR; Dhavan DS
    Colloids Surf B Biointerfaces; 2023 Nov; 231():113539. PubMed ID: 37742362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanodelivery of triamcinolone acetonide with PLGA-chitosan nanoparticles for the treatment of ocular inflammation.
    Xing Y; Zhu L; Zhang K; Li T; Huang S
    Artif Cells Nanomed Biotechnol; 2021 Dec; 49(1):308-316. PubMed ID: 33739906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Customized cationic nanoemulsions loading triamcinolone acetonide for corneal neovascularization secondary to inflammatory processes.
    Fernandes AR; Vidal LB; Sánchez-López E; Dos Santos T; Granja PL; Silva AM; Garcia ML; Souto EB
    Int J Pharm; 2022 Jul; 623():121938. PubMed ID: 35728716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and Pharmacokinetics of Triamcinolone Acetonide-Loaded Liposomes Topical Formulations for Vitreoretinal Drug Delivery.
    Altamirano-Vallejo JC; Navarro-Partida J; Gonzalez-De la Rosa A; Hsiao JH; Olguín-Gutierrez JS; Gonzalez-Villegas AC; Keller BC; Bouzo-Lopez L; Santos A
    J Ocul Pharmacol Ther; 2018 Jun; 34(5):416-425. PubMed ID: 29584529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of Triamcinolone Acetonide-Loaded Microemulsion as a Prospective Ophthalmic Delivery System for Treatment of Uveitis: In Vitro and In Vivo Evaluation.
    Mahran A; Ismail S; Allam AA
    Pharmaceutics; 2021 Mar; 13(4):. PubMed ID: 33805986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluations of therapeutic efficacy of intravitreal injected polylactic-glycolic acid microspheres loaded with triamcinolone acetonide on a rabbit model of uveitis.
    Li W; He B; Dai W; Zhang Q; Liu Y
    Int Ophthalmol; 2014 Jun; 34(3):465-76. PubMed ID: 23868505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved anti-inflammatory effects in rabbit eye model using biodegradable poly beta-amino ester nanoparticles of triamcinolone acetonide.
    Sabzevari A; Adibkia K; Hashemi H; De Geest BG; Mohsenzadeh N; Atyabi F; Ghahremani MH; Khoshayand MR; Dinarvand R
    Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5520-6. PubMed ID: 23833065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triamcinolone acetonide loaded-cationic nano-lipoidal formulation for uveitis: Evidences of improved biopharmaceutical performance and anti-inflammatory activity.
    Nirbhavane P; Sharma G; Singh B; Begum G; Jones MC; Rauz S; Vincent R; Denniston AK; Hill LJ; Katare OP
    Colloids Surf B Biointerfaces; 2020 Jun; 190():110902. PubMed ID: 32143010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subconjunctival triamcinolone acetonide in the management of ocular inflammatory disease.
    Athanasiadis Y; Tsatsos M; Sharma A; Hossain P
    J Ocul Pharmacol Ther; 2013; 29(6):516-22. PubMed ID: 23485045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melt-Cast Films Significantly Enhance Triamcinolone Acetonide Delivery to the Deeper Ocular Tissues.
    Tatke A; Dudhipala N; Janga KY; Soneta B; Avula B; Majumdar S
    Pharmaceutics; 2019 Apr; 11(4):. PubMed ID: 30987011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycyrrhizin could reduce ocular hypertension induced by triamcinolone acetonide in rabbits.
    Song Z; Gong Y; Liu H; Ren Q; Sun X
    Mol Vis; 2011; 17():2056-64. PubMed ID: 21850181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitreous pharmacokinetics and retinal safety of intravitreal preserved versus non-preserved triamcinolone acetonide in rabbit eyes.
    Oliveira RC; Messias A; Siqueira RC; Bonini-Filho MA; Haddad A; Damico FM; Maia-Filho A; Crispim PT; Saliba JB; Ribeiro JA; Scott IU; Cunha AS; Jorge R
    Curr Eye Res; 2012 Jan; 37(1):55-61. PubMed ID: 22029458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymeric triamcinolone acetonide nanoparticles as a new alternative in the treatment of uveitis: in vitro and in vivo studies.
    Sabzevari A; Adibkia K; Hashemi H; Hedayatfar A; Mohsenzadeh N; Atyabi F; Ghahremani MH; Dinarvand R
    Eur J Pharm Biopharm; 2013 May; 84(1):63-71. PubMed ID: 23295645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suprachoroidal Injection of Triamcinolone Acetonide Suspension: Ocular Pharmacokinetics and Distribution in Rabbits Demonstrates High and Durable Levels in the Chorioretina.
    Muya L; Kansara V; Cavet ME; Ciulla T
    J Ocul Pharmacol Ther; 2022; 38(6):459-467. PubMed ID: 35404132
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.